表紙
市場調查報告書

老年癡呆症診斷檢查裝置:醫療設備的開發平台評估

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 351350
出版日期 內容資訊 英文 291 Pages
訂單完成後即時交付
價格
老年癡呆症診斷檢查裝置:醫療設備的開發平台評估 Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年10月31日內容資訊: 英文 291 Pages
簡介

本報告提供老年癡呆症診斷檢查裝置的開發中產品相關調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的最近事件等資訊。

第1章 目錄

第2章 簡介

  • 老年癡呆症診斷檢查裝置概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:地區 (國家) 別
  • 開發中產品:法規途徑別
  • 開發中產品:核准時期別 (估計)
  • 進行中臨床實驗

第4章 老年癡呆症診斷檢查裝置 - 正在開發的開發中產品:各企業

  • 老年癡呆症診斷檢查裝置的開發企業 - 開發中產品:各開發階段
  • 開發中產品:各開發階段

第5章 老年癡呆症診斷檢查裝置的開發企業與產品概要

  • AC Immune SA
  • Acobiom
  • Acumen Pharmaceuticals, Inc.
  • Adlyfe Inc.
  • Advanced Genomic Technology, LLC
  • ADx NeuroSciences NV
  • Akrivis Technologies, LLC
  • Alere Inc.
  • Alzhyme Pty Ltd
  • Amarantus Bioscience Holdings, Inc.
  • Applied Proteomics, Inc.
  • Araclon Biotech, S.L.
  • Banyan Biomarkers, Inc.
  • BioArctic Neuroscience AB
  • biOasis Technologies Inc.
  • Biomedical Development Corporation
  • BioSystems International
  • C2N Diagnostics LLC
  • Chronix Biomedical, Inc.
  • Cognoptix, Inc.
  • Columbia University
  • CompanDX Ltd.
  • Consejo Superior de Investigaciones Cientificas
  • Cymedx
  • DiaGenic ASA
  • DiamiR LLC
  • DiaPat GmbH
  • Diaxonhit S.A.
  • Dr. Grossegger & Drbal GmbH
  • DS Pharma Biomedical Co., Ltd.
  • Durin Technologies, Inc.
  • Emory University
  • Fianostics GmbH
  • Gene Solutions LLC
  • GeneNews Limited
  • Genentech, Inc.
  • Georg-August-Universitat Gottingen
  • Ghent University
  • HealthTell, Inc.
  • ICDD-sas
  • Innovative California Biosciences International, Inc.
  • Innovative Health Diagnostics
  • Institut National de la Sante et de la Recherche Medicale
  • Instituto de Estructura de la Materia
  • Integrated Diagnostics Inc.
  • Janssen Pharmaceutica N.V.
  • KineMed, Inc.
  • Laboratory Corporation of America Holdings
  • McGill University Health Center
  • Memory Dx, LLC
  • Meso Scale Diagnostics LLC
  • Myriad Genetics, Inc.
  • NanoSomiX, Inc.
  • Nanosphere, Inc.
  • Neuron Biopharma SA
  • NeuroQuest, Ltd.
  • Neurotrope Bioscience, Inc.
  • NeuroVision Imaging LLC.
  • Newcastle University
  • NextGen Sciences Dx Inc
  • Novel Bio-spectrum Technologies, Inc.
  • Oligomerix, inc.
  • OPKO Health, Inc.
  • Orasi Medical, Inc.
  • Oregon Health & Science University
  • Oryzon Genomics S.A.
  • Oxford Biodynamics Limited
  • PDx BioTech
  • PeriRx LLC
  • Pre Diagnostics AS
  • Predemtec GmbH
  • ProMIS Neurosciences Inc.
  • Proplex Technologies, Llc
  • Protagen AG
  • Proteome Sciences Plc
  • Proteomics International Pty Ltd
  • Quanterix Corporation
  • Redox Diagnostics LLC
  • Saladax Biomedical, Inc.
  • Satoris, Inc.
  • Scout Diagnostics, LLC
  • Singulex, Inc.
  • SomaLogic, Inc.
  • Takeda Pharmaceuticals International AG
  • The Johns Hopkins University
  • The University of Melbourne
  • Trinity College Dublin
  • True Diagnostics, Inc.
  • University of California, Irvine
  • University of Chicago
  • University of Georgia
  • University of Luxembourg
  • University of Nottingham
  • University of South Florida
  • University of Texas Health Science Center at Houston
  • University of Texas Southwestern Medical Center at Dallas
  • US Biomarkers, Inc.
  • Vermillion, Inc.
  • Vitruvian Biomedical, Inc.
  • Washington University in St. Louis
  • XRGenomics LTD
  • Zoiray Technologies Inc.

第6章 老年癡呆症診斷檢查裝置 - 最近的事件

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1022EPD

GlobalData's Medical Devices sector report, "Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Alzheimer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Alzheimer Diagnostic Tests are test that detects the disease before it causes the symptoms. It measures key proteins or protein patterns in blood or spinal fluid (biomarkers).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Alzheimer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Alzheimer Overview

3 Products under Development

  • 3.1 Alzheimer - Pipeline Products by Stage of Development
  • 3.2 Alzheimer - Pipeline Products by Territory
  • 3.3 Alzheimer - Pipeline Products by Regulatory Path
  • 3.4 Alzheimer - Pipeline Products by Estimated Approval Date
  • 3.5 Alzheimer - Ongoing Clinical Trials

4 Alzheimer - Pipeline Products under Development by Companies

  • 4.1 Alzheimer Companies - Pipeline Products by Stage of Development
  • 4.2 Alzheimer - Pipeline Products by Stage of Development

5 Alzheimer Companies and Product Overview

6 Alzheimer- Recent Developments

7. Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Alzheimer - Pipeline Products by Stage of Development
  • Table 2: Alzheimer - Pipeline Products by Territory
  • Table 3: Alzheimer - Pipeline Products by Regulatory Path
  • Table 4: Alzheimer - Pipeline Products by Estimated Approval Date

T

List of Figures

List of Figures

  • Figure 1: Alzheimer - Pipeline Products by Stage of Development
  • Figure 2: Alzheimer - Pipeline Products by Territory
  • Figure 3: Alzheimer - Pipeline Products by Regulatory Path
  • Figure 4: Alzheimer - Pipeline Products by Estimated Approval Date
  • Figure 5: Alzheimer - Ongoing Clinical Trials